Skip to content

Clinical trials

Observational Neuroblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Observational Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20062
20075
200810
20095
20106
20119
20125
20133
20141
20164
20172
20183
20192
20213
20223
20232
20245
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting16
Unknown status9
Terminated8
Active, not recruiting6
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group19
National Taiwan University Hospital7
National Cancer Institute (NCI)5
Memorial Sloan Kettering Cancer Center4
St. Jude Children's Research Hospital4
Vanderbilt-Ingram Cancer Center4
British Columbia Cancer Agency2
Dana-Farber Cancer Institute2
Mayo Clinic2
Nanjing First Hospital, Nanjing Medical University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma83
Neoplasms14
Wilms Tumor11
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Sarcoma10
Breast Neoplasms9
Hodgkin Disease9
Lymphoma9
Burkitt Lymphoma8
Leukemia8

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.